세계의 슬관절 점액낭염 시장 보고서(2025년)

Knee bursitis occurs when one or more of the small, fluid-filled sacs near the knee joint become inflamed. These sacs, called bursae, cushion and reduce friction between tissues such as bones, tendons, and muscles. Inflammation of these bursae leads to symptoms such as pain, swelling, and limited movement in the knee.

Diagnosis of knee bursitis typically involves imaging tests such as ultrasound or MRI scans. These tests help visualize inflammation and fluid buildup in the bursae surrounding the knee joint. Treatment options include medication and, in some cases, surgery. These treatments are utilized by hospitals, clinics, diagnostic centers, research institutions, academic establishments, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The knee bursitis research report is one of a series of new reports from The Business Research Company that provides knee bursitis market statistics, including the knee bursitis industry's global market size, regional shares, competitors with a knee bursitis market share, detailed knee bursitis market segments, market trends and opportunities, and any further data you may need to thrive in the knee bursitis industry. This knee bursitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The knee bursitis market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.86 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to an aging population, increased participation in sports and physical activities, improved diagnostic techniques, improved access to healthcare services, and education programs for healthcare professionals and patients.

The knee bursitis market size is expected to see strong growth in the next few years. It will grow to $3.72 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increased awareness campaigns about prevention and management, growth in disposable income, rising healthcare expenditure, and increasing awareness and diagnosis of knee bursitis. Major trends in the forecast period include advancements in diagnostic techniques, the development of novel therapies, advancements in research and development activities, and telemedicine and remote monitoring.

The forecast of 6.8% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of therapeutic ultrasound machines and corticosteroid injection kits sourced from South Korea and Italy, thereby prolonging pain management timelines and elevating orthopedic clinic expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of bone-related diseases, such as osteoporosis, arthritis, and bone cancer, is expected to drive the expansion of the knee bursitis market in the future. These diseases affect the skeletal system's structure, strength, and functionality, and are increasingly prevalent due to factors such as aging populations, sedentary lifestyles, poor nutrition, and environmental changes. Conditions such as osteoarthritis and rheumatoid arthritis can lead to knee bursitis by causing inflammation and excessive pressure on the knee bursa, resulting in pain, swelling, and reduced joint function. For example, Healthy Bones Australia projected in September 2022 that Australia would have 6.2 million individuals aged 50 and above suffering from osteoporosis or osteopenia in 2022, highlighting the significant impact of poor bone health on knee-related conditions. Therefore, the rising prevalence of bone-related diseases is a key driver of growth in the knee bursitis market.

The anticipated growth of the knee bursitis market is expected to be driven by the increasing diabetic population in the coming years. Diabetes, a chronic condition characterized by the body's inability to regulate blood sugar levels effectively, results from insufficient insulin production or ineffective insulin use. Factors contributing to the rise in diabetes cases include sedentary lifestyles, unhealthy dietary habits, and genetic predispositions. Diabetic individuals are at higher risk of developing knee bursitis due to inflammation caused by prolonged pressure on the knees, impaired immune function, or complications related to diabetes. For instance, a July 2021 report by the International Diabetes Federation projected a substantial increase in the global diabetic population, estimating 643 million people living with diabetes by 2030 and 783 million by 2045. Therefore, the expanding diabetic population is a key driver behind the expected growth of the knee bursitis market.

The growing diabetic population is expected to drive the growth of the knee bursitis market in the future. Diabetes is a chronic condition in which the body struggles to regulate blood sugar levels due to either insufficient insulin production or ineffective insulin use. The rise in diabetes cases is linked to factors such as sedentary lifestyles, poor dietary habits, and genetic factors. Diabetic individuals may develop knee bursitis as a result of inflammation from prolonged pressure on the knees, weakened immune function, or diabetes-related complications. For example, in June 2024, a report from the National Health Service (NHS), a UK-based public health organization, revealed that in 2023, the number of people registered with pre-diabetes rose to 3,615,330, up from 3,065,825 in 2022, an 18% increase. Therefore, the growing diabetic population is fueling the expansion of the knee bursitis market.

Major companies operating in the knee bursitis market are Pfizer Inc., Merck & Co. Inc, Bayer AG, Novartis AG, Roche Holding AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Gilead Sciences Inc., Stryker Corporation, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Zimmer Biomet Holdings Inc., DePuy Synthes Inc., Arthrex Inc., Globus Medical Inc., Bioventus LLC, Exactech Inc., Genentech Inc., Conformis Inc., Oncolys BioPharma Inc, Bellicum Pharmaceuticals Inc, Merrimack Pharmaceuticals Inc, 4Med Medical Solutions Inc

North America was the largest region in the knee bursitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee bursitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the knee bursitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The knee bursitis market consists of revenues earned by entities by providing services such as medical consultation, medication management, surgical intervention, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The knee bursitis market also includes sales of knee braces and supports, cold packs and heat wraps, anti-inflammatory medications, and corticosteroid injections. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Knee Bursitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on knee bursitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for knee bursitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The knee bursitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Diagnosis: Imaging Test; Other Diagnosis Tests
• 2) By Treatment: Medication; Therapy; Surgery; Other Treatments
• 3) By End User: Hospitals And Clinics; Diagnostic Centers; Research Centers; Academic Institutes; Other End Users
• Subsegments:
• 1) By Imaging Test: X-Ray; MRI (Magnetic Resonance Imaging); Ultrasound
• 2) By Other Diagnosis Tests: Physical Examination; Aspiration Of Joint Fluid; Blood Tests
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc; Bayer AG; Novartis AG; Roche Holding AG; Medtronic plc; Eli Lilly and Company; Amgen Inc; Gilead Sciences Inc.; Stryker Corporation; Regeneron Pharmaceuticals Inc.; Biogen Inc.; Vertex Pharmaceuticals Incorporated; Zimmer Biomet Holdings Inc.; DePuy Synthes Inc.; Arthrex Inc.; Globus Medical Inc.; Bioventus LLC; Exactech Inc.; Genentech Inc.; Conformis Inc.; Oncolys BioPharma Inc; Bellicum Pharmaceuticals Inc; Merrimack Pharmaceuticals Inc; 4Med Medical Solutions Inc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Knee Bursitis Market Characteristics

3. Knee Bursitis Market Trends And Strategies

4. Knee Bursitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Knee Bursitis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Knee Bursitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Knee Bursitis Market Growth Rate Analysis
• 5.4. Global Knee Bursitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Knee Bursitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Knee Bursitis Total Addressable Market (TAM)

6. Knee Bursitis Market Segmentation

• 6.1. Global Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Test
• Other Diagnosis Tests
• 6.2. Global Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Therapy
• Surgery
• Other Treatments
• 6.3. Global Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Centers
• Research Centers
• Academic Institutes
• Other End Users
• 6.4. Global Knee Bursitis Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• X-Ray
• MRI (Magnetic Resonance Imaging)
• Ultrasound
• 6.5. Global Knee Bursitis Market, Sub-Segmentation Of Other Diagnosis Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Examination
• Aspiration Of Joint Fluid
• Blood Tests

7. Knee Bursitis Market Regional And Country Analysis

• 7.1. Global Knee Bursitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Knee Bursitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Knee Bursitis Market

• 8.1. Asia-Pacific Knee Bursitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Knee Bursitis Market

• 9.1. China Knee Bursitis Market Overview
• 9.2. China Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Knee Bursitis Market

• 10.1. India Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Knee Bursitis Market

• 11.1. Japan Knee Bursitis Market Overview
• 11.2. Japan Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Knee Bursitis Market

• 12.1. Australia Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Knee Bursitis Market

• 13.1. Indonesia Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Knee Bursitis Market

• 14.1. South Korea Knee Bursitis Market Overview
• 14.2. South Korea Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Knee Bursitis Market

• 15.1. Western Europe Knee Bursitis Market Overview
• 15.2. Western Europe Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Knee Bursitis Market

• 16.1. UK Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Knee Bursitis Market

• 17.1. Germany Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Knee Bursitis Market

• 18.1. France Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Knee Bursitis Market

• 19.1. Italy Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Knee Bursitis Market

• 20.1. Spain Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Knee Bursitis Market

• 21.1. Eastern Europe Knee Bursitis Market Overview
• 21.2. Eastern Europe Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Knee Bursitis Market

• 22.1. Russia Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Knee Bursitis Market

• 23.1. North America Knee Bursitis Market Overview
• 23.2. North America Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Knee Bursitis Market

• 24.1. USA Knee Bursitis Market Overview
• 24.2. USA Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Knee Bursitis Market

• 25.1. Canada Knee Bursitis Market Overview
• 25.2. Canada Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Knee Bursitis Market

• 26.1. South America Knee Bursitis Market Overview
• 26.2. South America Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Knee Bursitis Market

• 27.1. Brazil Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Knee Bursitis Market

• 28.1. Middle East Knee Bursitis Market Overview
• 28.2. Middle East Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Knee Bursitis Market

• 29.1. Africa Knee Bursitis Market Overview
• 29.2. Africa Knee Bursitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Knee Bursitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Knee Bursitis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Knee Bursitis Market Competitive Landscape And Company Profiles

• 30.1. Knee Bursitis Market Competitive Landscape
• 30.2. Knee Bursitis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

31. Knee Bursitis Market Other Major And Innovative Companies

• 31.1. Medtronic plc
• 31.2. Eli Lilly and Company
• 31.3. Amgen Inc
• 31.4. Gilead Sciences Inc.
• 31.5. Stryker Corporation
• 31.6. Regeneron Pharmaceuticals Inc.
• 31.7. Biogen Inc.
• 31.8. Vertex Pharmaceuticals Incorporated
• 31.9. Zimmer Biomet Holdings Inc.
• 31.10. DePuy Synthes Inc.
• 31.11. Arthrex Inc.
• 31.12. Globus Medical Inc.
• 31.13. Bioventus LLC
• 31.14. Exactech Inc.
• 31.15. Genentech Inc.

32. Global Knee Bursitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Knee Bursitis Market

34. Recent Developments In The Knee Bursitis Market

35. Knee Bursitis Market High Potential Countries, Segments and Strategies

• 35.1 Knee Bursitis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Knee Bursitis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Knee Bursitis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer